Legal Representation
Attorney
Nicole Kinsley, Esq.
USPTO Deadlines
Next Deadline
1779 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-06-18)
Due Date
June 18, 2030
Grace Period Ends
December 18, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 18, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jun 18, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 13, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| May 13, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Apr 1, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Apr 1, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 9, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 8, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Mar 8, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 8, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 8, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 8, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Oct 3, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 8, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 8, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 19, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 3, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 30, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 30, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 30, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 30, 2023 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Jun 30, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 30, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 30, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| May 23, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 23, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 23, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 21, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 26, 2023 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Dec 21, 2022 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Dec 20, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 1, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Business administration of patient pharmaceutical reimbursement programs; business administration of a patient support program for facilitating access to, distribution of, and reimbursement for pharmaceutical products
First Use Anywhere:
20240100
First Use in Commerce:
20240100
Class 036
Providing health insurance information about health insurance benefits, medication insurance coverage, insurance reimbursement, insurance payer policies and patient financial assistance to patients; financial consultation to medical patients in identification of health insurance alternatives; providing patient assistance programs, namely, providing financial assistance programs to provide access to pharmaceutical preparations at low or no cost to qualified uninsured and underinsured patients who have a demonstrated financial need
First Use Anywhere:
20240100
First Use in Commerce:
20240100
Class 044
Informational counseling for patients, namely, providing information and assistance with respect to obtaining prescription medications for medical purposes
First Use Anywhere:
20240100
First Use in Commerce:
20240100
Additional Information
Design Mark
The mark consists of the word "ELAHERE" in block capital letters, stacked above "mirvetuximab soravtansine", "injection 100 mg", and "SUPPORT SERVICES", with the design of a half circle sunburst to the left of these words made up of trapezoid-shaped lines, each divided into three sections of different shades, arrayed around the upper left corner of the first "E" in "ELAHERE".
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION ONE ZERO ZERO MG SUPPORT SERVICES; ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION ONE HUNDRED MG SUPPORT SERVICES
Classification
International Classes
035
036
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"SUPPORT SERVICES" AND "MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG"